Home › USFDA Tracker › Piramal Pharma

Piramal Pharma — USFDA Status

Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Piramal Pharma (NSE: PPLPHARMA, BSE: 543635), from US FDA records and exchange filings.

80
Compliance score (5 years) · how
3
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified VAI — 13 Feb 2026 (Kohir Mandal, Sangareddy District plant). Source: FDA Data Dashboard.
USFDA events by year
2023
2025
2026
NAIVAIForm 483OAIWarning letterImport alertUS approval

Plants

PlantFEILatest resultLast inspectionHistory (newest first)
Kohir Mandal, Sangareddy District
Piramal Pharma Limited
3003803288 VAI 13 Feb 2026
Navi Mumbai
Piramal Pharma Limited
3008763768 VAI 17 Feb 2025
Pithampur
Piramal Pharma Limited
3005259207 NAI 19 May 2023

Full USFDA timeline

13 Feb 2026
VAI — minor issues
USFDA inspection classified VAI
Kohir Mandal, Sangareddy District · FEI 3003803288 · Piramal Pharma Limited, Kohir Mandal, Sangareddy District — Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary)
17 Feb 2025
VAI — minor issues
USFDA inspection classified VAI
Navi Mumbai · FEI 3008763768 · Piramal Pharma Limited, Navi Mumbai — Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary)
19 May 2023
NAI — clean
USFDA inspection classified NAI
Pithampur · FEI 3005259207 · Piramal Pharma Limited, Pithampur — Drug Quality Assurance (Drugs)
31 Mar 2023
NAI — clean
USFDA inspection classified NAI
Kohir Mandal, Sangareddy District · FEI 3003803288 · Piramal Pharma Limited, Kohir Mandal, Sangareddy District — Drug Quality Assurance (Drugs)
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/piramal-pharma